Audit 402131

FY End
2021-12-31
Total Expended
$1.26M
Findings
0
Programs
1
Organization: COAPTECH INC (MD)
Year: 2021 Accepted: 2026-05-26

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research $1.26M Yes 0

Contacts

Name Title Type
V2QJESMXQN25 Howard Carolan Auditee
4109292268 Scott Rodgville Auditor
No contacts on file

Notes to SEFA

The accompanying Schedule of Expenditures of Federal Awards includes the federal grant activity of CoapTech, LLC (the Company), and is presented on the accrual basis of accounting. The information in this schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200 Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (the Uniform Guidance). Because this schedule presents only a selected portion of the operations of the Company, it is not intended and does not present the financial position, change in net assets, or cash flows of the Company. Therefore, some amounts presented in this schedule may differ from amounts presented in, or used in the preparation of, the financial statements. The Company has elected to use the 15-percent de minimis indirect cost rate allowed under the Uniform Guidance.